(Q53449089)

14 May 2018

title

Promoter CpG island hypermethylation during breast cancer progression. (English)

1 reference

14 May 2018

1 reference

1 reference

So Yeon Park

1

0 references

Gyeong Hoon Kang

object named as

Gyeong Hoon Kang

10

0 references

author name string

Hyeong Ju Kwon

2

1 reference

14 May 2018

Hee Eun Lee

3

1 reference

14 May 2018

Han Suk Ryu

4

1 reference

14 May 2018

Sung-Won Kim

5

1 reference

14 May 2018

Jee Hyun Kim

6

1 reference

14 May 2018

In Ah Kim

7

1 reference

14 May 2018

Namhee Jung

8

1 reference

14 May 2018

Nam-Yun Cho

9

1 reference

14 May 2018

publication date

1 December 2010

1 reference

14 May 2018

published in

Virchows Archiv

1 reference

14 May 2018

volume

458

1 reference

14 May 2018

issue

1

1 reference

14 May 2018

page(s)

73-84

1 reference

14 May 2018

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

cites work

1 reference

12 December 2020

Quantitative assessment of promoter hypermethylation during breast cancer development

1 reference

12 December 2020

Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis

1 reference

12 December 2020

Profile of aberrant CpG island methylation along multistep gastric carcinogenesis.

1 reference

12 December 2020

DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis

1 reference

12 December 2020

Risk factors for breast cancer in women with proliferative breast disease

1 reference

12 December 2020

Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer

1 reference

12 December 2020

Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma

1 reference

12 December 2020

Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer

1 reference

12 December 2020

Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression

1 reference

12 December 2020

Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies

1 reference

12 December 2020

Analysis of gene expression in ductal carcinoma in situ of the breast.

1 reference

12 December 2020

Homeobox genes and axial patterning

1 reference

12 December 2020

Analysis of repetitive element DNA methylation by MethyLight

1 reference

12 December 2020

Patterns of chromosomal alterations in breast ductal carcinoma in situ

1 reference

12 December 2020

Gene expression profiles of human breast cancer progression

1 reference

12 December 2020

Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors

1 reference

12 December 2020

Multistep carcinogenesis of breast cancer and tumour heterogeneity

1 reference

12 December 2020

Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.

1 reference

12 December 2020

Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer

1 reference

12 December 2020

Cell type-specific DNA methylation patterns in the human breast

1 reference

12 December 2020

Quantification of CpG island methylation in progressive breast lesions from normal to invasive carcinoma

1 reference

12 December 2020

The effect of chromosome 17 polysomy on HER-2/neu status in breast cancer

1 reference

12 December 2020

Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer

1 reference

12 December 2020

A gene hypermethylation profile of human cancer

1 reference

12 December 2020

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

1 reference

12 December 2020

Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia

1 reference

12 December 2020

Correlation between CpG methylation profiles and hormone receptor status in breast cancers

1 reference

12 December 2020

A comparative study of Korean with Caucasian breast cancer reveals frequency of methylation in multiple genes correlates with breast cancer in young, ER, PR-negative breast cancer in Korean women

1 reference

12 December 2020

MT1G hypermethylation is associated with higher tumor stage in prostate cancer

1 reference

12 December 2020

DNA methylation and breast carcinogenesis.

1 reference

12 December 2020

DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers

1 reference

12 December 2020

Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma

1 reference

12 December 2020

Basal-like breast cancer displays distinct patterns of promoter methylation

1 reference

12 December 2020

Quantitative promoter hypermethylation profiles of ductal carcinoma in situ in North American and Korean women: Potential applications for diagnosis.

1 reference

12 December 2020

Identification of novel epigenetic markers for clear cell renal cell carcinoma

1 reference

12 December 2020

HOXA10 regulates p53 expression and matrigel invasion in human breast cancer cells

1 reference

12 December 2020

Aberrant CpG Island Hypermethylation Along Multistep Hepatocarcinogenesis

1 reference

12 December 2020

HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells

1 reference

12 December 2020

DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma

1 reference

12 December 2020

Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution

1 reference

12 December 2020

Methylation of CpG islands of p16(INK4a) and cyclinD1 overexpression associated with progression of intraductal proliferative lesions of the breast.

1 reference

12 December 2020

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

1 reference

12 December 2020

RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression.

1 reference

12 December 2020

GSTP1 promoter hypermethylation is an early event in breast carcinogenesis

1 reference

12 December 2020

10.1007/S00428-010-1013-6

Identifiers

DOI

1 reference

14 May 2018

1 reference

14 May 2018